Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/10/2005WO2004104033A3 Viruses dependent on inducing agents for viral entry into a host cell
03/10/2005WO2004101768A3 Recombinant comamonas testosreroni 5-mgam-4d amids and carboxylic acid production
03/10/2005WO2004098497A3 Cd4+ human papillomavirus (hpv) epitopes
03/10/2005WO2004094641A3 A novel method of modulating bone-realted activity
03/10/2005WO2004081040A3 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
03/10/2005WO2004081031A3 Thiol-mediated drug attachment to targeting peptides
03/10/2005WO2004078907A3 Streptococcus pyogenes antigens
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004070351A3 Protein fragment complementation assays for high-throughput and high-content screening
03/10/2005WO2004058808A3 Dna vaccines against hantavirus infections
03/10/2005WO2004055161A3 Large scale production of packaged alphavirus replicons
03/10/2005WO2004053091A3 STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES
03/10/2005WO2004048411A3 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
03/10/2005WO2004044182A3 Highly permissive cell lines for hepatitis c virus replication
03/10/2005WO2004035753B1 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis
03/10/2005WO2004016732A3 Astrocyte modulated genes and uses thereof
03/10/2005WO2004013609A8 Use of biomarkers for detecting ovarian cancer
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003093409A3 Promoters exhibiting endothelial cell specificity and methods of using same
03/10/2005WO2003079987A3 A non-selective cation channel in neural cells and methods for treating brain swelling
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
03/10/2005WO2003065003A3 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
03/10/2005WO2003027254A9 15625 receptor, a novel g-protein coupled receptor
03/10/2005WO2003010290A3 Novel class ii cytokine receptors and uses thereof
03/10/2005WO2002094989A3 Retroviral vectors and methods of using same
03/10/2005WO2002024894A9 Human protease inhibitor proteins and polynucleotides encod ing the same
03/10/2005WO2001011335A3 Antiviral compounds that inhibit viral replication
03/10/2005US20050055746 Enhancing leaf protein concentration in plant via transformmation with vector comprising nucleotide sequences which code for serine and aspartate protease inhibitors; tissue engineering and enhancing animal feeds
03/10/2005US20050055745 Leaf longevity protein (ORE-7) for use in controlling senescence in plants; enhancing crop yield, viability and growing season
03/10/2005US20050055742 Plant regulatory element
03/10/2005US20050055741 Transgenic plant comprising nucleotide sequences coding silencing element binding factor protein (SEBF) for use in identifying modulator which enhance/decrease plants resistance pathogens; disease resistant plants
03/10/2005US20050055738 Methods and compositions for regulation of cell death in plants
03/10/2005US20050055735 Use of complement protein C3 and its derivatives in enhancing mammalian embryo development
03/10/2005US20050055733 Small intestine and colon genes
03/10/2005US20050054846 Method for generating influenza viruses and vaccines
03/10/2005US20050054845 Thymosin augmentation of genetic immunization
03/10/2005US20050054842 Intraflagellar transport
03/10/2005US20050054838 Recovering a calcium-sensitive luminescent protein via gradient elution chromatography
03/10/2005US20050054837 Activity dependent neurotrophic factor I complex (ADNF I complex) for use as tool in reducing conditions associated with fetal alcohol syndrome and enhancing learning and memory
03/10/2005US20050054835 Immunoglobulin fusion comprising gelonin and shiga-like toxin for use in treatment and prevention of graft vs host, autoimmue and cell proliferative disorders
03/10/2005US20050054830 Preparing recombinant fiber protein for use in cable, cord, twine, yarn, fishing line, netting, clothing fabric, bullet-proof vest lining, container fabric, adhesive binding/non-adhesive, strapping material, sheeting material, tent fabric, pool cover, vehicle cover, medical suture and sports equipment
03/10/2005US20050054829 Compositions and methods relating to TSP-30a, b, c and d
03/10/2005US20050054828 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
03/10/2005US20050054827 Conotoxin amino acid sequences for use as tool in controlling pain; immunotherapy; mimetics
03/10/2005US20050054826 Human diaphanous-3 gene and methods of use therefor
03/10/2005US20050054825 Osteogenic devices
03/10/2005US20050054824 Germ cell restricted polypeptide for use in tissue repair; tissue targeted therapy; regenerative medicine and tissue engineering
03/10/2005US20050054823 Genes
03/10/2005US20050054822 High in normal-2 (HIN-1) protein for use in the identifying modulators for treatment of infection and respiratory system disorders
03/10/2005US20050054821 Fusion proteins for insect control
03/10/2005US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054601 Modified polynucleotides with phosphorothiolate linkage; animal growth regulators; immunomoderators; immunotherapy ; autoimmune disease
03/10/2005US20050054593 New drug
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054579 New crystalline forms
03/10/2005US20050054578 Topical cosmetic which increases elasticity of skin; low molecular weight peptide
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054572 Methods for obtaining molecules with reduced immunogenicity
03/10/2005US20050054571 Antimicrobial proteins from the SPO1 bacteriophage
03/10/2005US20050054570 For prophylaxis and therapy of diabetes
03/10/2005US20050054569 Mutants and assay system to identify USP/RXR ligands
03/10/2005US20050054568 Angiogenesis-modulating compositions and uses
03/10/2005US20050054566 Calcium-influx inhibitory factor and method of isolation thereof
03/10/2005US20050054565 Agonists and antagonists of moxifin for the treatment of metabolic disorders
03/10/2005US20050054564 Proteins for use in treatment of gastrointestinal disorders; novel gene product designated Antrum Mucosal Protein 18 ("AMP-18") is a gastrokine
03/10/2005US20050054563 Transgenic bacteria host cell can be used for screening antibiotics , herbicides; genetic engineering; therapy for bone disorders; antiarthritic agents
03/10/2005US20050054560 Cd44 variants carrying heparan sulfate chains and uses thereof
03/10/2005US20050054108 Yeast membrane protein expression system and its application in drug screening
03/10/2005US20050054107 Replicon particles comprising viral proteins for use in vaccines against viral disease; viricides
03/10/2005US20050054104 Expression vector for use in transfer of heterologous nucleotide sequences into cells expressing FLT3 (FMS-like tyrosine kinase 3); drug delivery; genetic vaccines
03/10/2005US20050054094 SPRR1A and axonal regeneration
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054075 Attenuated bacteria useful in vaccines
03/10/2005US20050054074 Cell line comprising embryonated poultry cells and attenuated viral particles for use as tool in generation of vaccine for treatment and prevention of in fection by of influenza virus; immunotherapeutics
03/10/2005US20050054062 Gene conferring lysozyme insensitivity to Corynebacterium
03/10/2005US20050054054 Therapeutic cytokine for use in prevention and treatment of cell proliferative disorders
03/10/2005US20050054053 Interferon variants with improved properties
03/10/2005US20050054052 Therapeutic cytokine for use in prevention and treatment of viral diseases
03/10/2005US20050054051 Albumin fusion proteins
03/10/2005US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering
03/10/2005US20050054049 Novel human transporter proteins and polynucleotides encoding the same
03/10/2005US20050054047 Modified tumor necrosis factor receptor for use in treatment and prevention of cell proliferative disorders; antitumor agents
03/10/2005US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents
03/10/2005US20050054045 Novel G-protein coupled receptor
03/10/2005US20050054043 Metal binding human transferrins for use as tool in removing toxic metals from patients in metal chelation therapy; tissue culture medium supplements
03/10/2005US20050054041 Kini-3 motor protein and methods for its use
03/10/2005US20050054040 Novel human semaphorin homologs and polynucleotides encoding the same
03/10/2005US20050054038 High level constitutive production of anthrax protective antigen
03/10/2005US20050054037 Ferroportin-1 mutant
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054035 Testicular carnitine transporter and its gene
03/10/2005US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing
03/10/2005US20050054033 Methods and compositions for treating and preventing infection using human interferon regulatory factor 3
03/10/2005US20050054016 Determination of bone-sialoprotein in bodily fluids for oncological problems
03/10/2005US20050053998 Methods for identifying and using maintenance genes
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053988 Gene expressed in breast cancer and methods of use
03/10/2005US20050053985 Multimeric protein comprising cleavage-polyadenylation specificity factor for use in identifying modulator for treatment and prevention of cell proliferative disorders
1 ... 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 ... 2916